Assay development and high throughput screening in the industrial arena, and more recently the public sector, has impacted the discovery of new lead and tool generation projects. IBC's 8th Annual Assay & Screening Advances conference will focus on how parallel strategies have influenced the rate and quality of chemical matter coming from screening efforts and have also created paradigm shifts in the way small molecule discovery is performed. In addition, sessions will identify areas in which both public and private screening centers can continue to improve and positively impact the productivity and generation of leads and tools for biomedical discovery.

Learn the latest on:

• Systems biology
• Primary tissue applications for screening
• Successful industry & academia screening strategies

Scientific Advisory Board

• James G. Evans Ph.D., Assistant Director, Whitehead MIT BioImaging Center
• Jim Inglese, Ph.D., Associate Investigator, Genome Technology Branch, National Institute of Health
• Sarah Payne, Ph.D., Director of Marketing, TTP LabTech Ltd.
• Gary Piazza, Ph.D., Professor of Pharmacology, Southern Research Institute
• D. Lansing Taylor, Ph.D., President and CEO, Cellumen, Inc.

View the Agenda

• Day One
• Day Two
• Day Three

View the other Tracks

• Protein Kinase Targets
• G-Protein Coupled Receptors
• Ion Channel Targets